Search

everythinglearnresearchcommunity

for

Search:↓

The HATMSC1 cell line from fat tissue can produce helpful factors for regenerative and immune therapies.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

The new treatment effectively heals drug-resistant bacteria-infected wounds.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Injecting alpha-melanocyte-stimulating hormone in mice improved skin healing and reduced scarring.

A woman with severe angioedema improved significantly after treatment with rituximab.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Immortalized hair follicle cells could be useful for regenerative medicine and treating inflammation and oxidative stress.

Enhancing immune response can improve cancer treatment effectiveness.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

PandaOmics uses AI to find new disease treatment targets and biomarkers.

Hair germ cells differ from epidermal cells in keratin expression, and specific keratins form after hair differentiation.

A(1-7) treatment reduces symptoms of lupus in mice.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

A man with rare skin changes on his fingers was diagnosed with multiple myeloma-linked amyloidosis.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

scMC effectively separates biological signals from technical noise in single-cell genomics data.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

M50054 may help treat hepatitis and hair loss from chemotherapy.